HCA Healthcare and its subsidiary HCA Inc. entered into an underwriting agreement on August 7, 2024, for the issuance of $3 billion in senior notes. The offering comprises three tranches: $750 million of 5.450% notes due 2031, $1.25 billion of 5.450% notes due 2034, and $1 billion of 5.950% notes due 2054.The 2031 notes will be additional notes under the existing indenture governing $1 billion of 5.450% Senior Notes due 2031 issued in February 2024. These new notes will have identical terms to the existing ones, except for the issue date and public offering price. They will be treated as a single series with the existing notes for all purposes under the indenture.The notes will be guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and will be issued under the company's Registration Statement on Form S-3. Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC are acting as representatives of the underwriters for this offering.

HCA Healthcare and its subsidiary HCA Inc. entered into an underwriting agreement on August 7, 2024, for the issuance of $3 billion in senior notes. The offering comprises three tranches: $750 million of 5.450% notes due 2031, $1.25 billion of 5.450% notes due 2034, and $1 billion of 5.950% notes due 2054.The 2031 notes will be additional notes under the existing indenture governing $1 billion of 5.450% Senior Notes due 2031 issued in February 2024. These new notes will have identical terms to the existing ones, except for the issue date and public offering price. They will be treated as a single series with the existing notes for all purposes under the indenture.The notes will be guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and will be issued under the company's Registration Statement on Form S-3. Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC are acting as representatives of the underwriters for this offering.